Lauren M Gardner1, András Bóta1, Karthik Gangavarapu2, Moritz U G Kraemer3,4,5, Nathan D Grubaugh2. 1. School of Civil and Environmental Engineering, UNSW Sydney, Sydney, New South Wales, Australia. 2. Department of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, United States of America. 3. Department of Zoology, University of Oxford, Oxford, United Kingdom. 4. Boston Children's Hospital, Boston, Massachusetts, United States of America. 5. Harvard Medical School, Boston, Massachusetts, United States of America.
Abstract
BACKGROUND: An unprecedented Zika virus epidemic occurred in the Americas during 2015-2016. The size of the epidemic in conjunction with newly recognized health risks associated with the virus attracted significant attention across the research community. Our study complements several recent studies which have mapped epidemiological elements of Zika, by introducing a newly proposed methodology to simultaneously estimate the contribution of various risk factors for geographic spread resulting in local transmission and to compute the risk of spread (or re-introductions) between each pair of regions. The focus of our analysis is on the Americas, where the set of regions includes all countries, overseas territories, and the states of the US. METHODOLOGY/PRINCIPAL FINDINGS: We present a novel application of the Generalized Inverse Infection Model (GIIM). The GIIM model uses real observations from the outbreak and seeks to estimate the risk factors driving transmission. The observations are derived from the dates of reported local transmission of Zika virus in each region, the network structure is defined by the passenger air travel movements between all pairs of regions, and the risk factors considered include regional socioeconomic factors, vector habitat suitability, travel volumes, and epidemiological data. The GIIM relies on a multi-agent based optimization method to estimate the parameters, and utilizes a data driven stochastic-dynamic epidemic model for evaluation. As expected, we found that mosquito abundance, incidence rate at the origin region, and human population density are risk factors for Zika virus transmission and spread. Surprisingly, air passenger volume was less impactful, and the most significant factor was (a negative relationship with) the regional gross domestic product (GDP) per capita. CONCLUSIONS/SIGNIFICANCE: Our model generates country level exportation and importation risk profiles over the course of the epidemic and provides quantitative estimates for the likelihood of introduced Zika virus resulting in local transmission, between all origin-destination travel pairs in the Americas. Our findings indicate that local vector control, rather than travel restrictions, will be more effective at reducing the risks of Zika virus transmission and establishment. Moreover, the inverse relationship between Zika virus transmission and GDP suggests that Zika cases are more likely to occur in regions where people cannot afford to protect themselves from mosquitoes. The modeling framework is not specific for Zika virus, and could easily be employed for other vector-borne pathogens with sufficient epidemiological and entomological data.
BACKGROUND: An unprecedented Zika virus epidemic occurred in the Americas during 2015-2016. The size of the epidemic in conjunction with newly recognized health risks associated with the virus attracted significant attention across the research community. Our study complements several recent studies which have mapped epidemiological elements of Zika, by introducing a newly proposed methodology to simultaneously estimate the contribution of various risk factors for geographic spread resulting in local transmission and to compute the risk of spread (or re-introductions) between each pair of regions. The focus of our analysis is on the Americas, where the set of regions includes all countries, overseas territories, and the states of the US. METHODOLOGY/PRINCIPAL FINDINGS: We present a novel application of the Generalized Inverse Infection Model (GIIM). The GIIM model uses real observations from the outbreak and seeks to estimate the risk factors driving transmission. The observations are derived from the dates of reported local transmission of Zika virus in each region, the network structure is defined by the passenger air travel movements between all pairs of regions, and the risk factors considered include regional socioeconomic factors, vector habitat suitability, travel volumes, and epidemiological data. The GIIM relies on a multi-agent based optimization method to estimate the parameters, and utilizes a data driven stochastic-dynamic epidemic model for evaluation. As expected, we found that mosquito abundance, incidence rate at the origin region, and human population density are risk factors for Zika virus transmission and spread. Surprisingly, air passenger volume was less impactful, and the most significant factor was (a negative relationship with) the regional gross domestic product (GDP) per capita. CONCLUSIONS/SIGNIFICANCE: Our model generates country level exportation and importation risk profiles over the course of the epidemic and provides quantitative estimates for the likelihood of introduced Zika virus resulting in local transmission, between all origin-destination travel pairs in the Americas. Our findings indicate that local vector control, rather than travel restrictions, will be more effective at reducing the risks of Zika virus transmission and establishment. Moreover, the inverse relationship between Zika virus transmission and GDP suggests that Zika cases are more likely to occur in regions where people cannot afford to protect themselves from mosquitoes. The modeling framework is not specific for Zika virus, and could easily be employed for other vector-borne pathogens with sufficient epidemiological and entomological data.
Authors: Mathilde Guerbois; Ildefonso Fernandez-Salas; Sasha R Azar; Rogelio Danis-Lozano; Celia M Alpuche-Aranda; Grace Leal; Iliana R Garcia-Malo; Esteban E Diaz-Gonzalez; Mauricio Casas-Martinez; Shannan L Rossi; Samanta L Del Río-Galván; Rosa M Sanchez-Casas; Christopher M Roundy; Thomas G Wood; Steven G Widen; Nikos Vasilakis; Scott C Weaver Journal: J Infect Dis Date: 2016-07-19 Impact factor: 5.226
Authors: Isaac I Bogoch; Oliver J Brady; Moritz U G Kraemer; Matthew German; Maria I Creatore; Shannon Brent; Alexander G Watts; Simon I Hay; Manisha A Kulkarni; John S Brownstein; Kamran Khan Journal: Lancet Infect Dis Date: 2016-09-01 Impact factor: 25.071
Authors: Rita W Driggers; Cheng-Ying Ho; Essi M Korhonen; Suvi Kuivanen; Anne J Jääskeläinen; Teemu Smura; Avi Rosenberg; D Ashley Hill; Roberta L DeBiasi; Gilbert Vezina; Julia Timofeev; Fausto J Rodriguez; Lev Levanov; Jennifer Razak; Preetha Iyengar; Andrew Hennenfent; Richard Kennedy; Robert Lanciotti; Adre du Plessis; Olli Vapalahti Journal: N Engl J Med Date: 2016-03-30 Impact factor: 91.245
Authors: Tomasz J Nowakowski; Alex A Pollen; Elizabeth Di Lullo; Carmen Sandoval-Espinosa; Marina Bershteyn; Arnold R Kriegstein Journal: Cell Stem Cell Date: 2016-03-30 Impact factor: 24.633
Authors: Nathan D Grubaugh; Jason T Ladner; Moritz U G Kraemer; Gytis Dudas; Amanda L Tan; Karthik Gangavarapu; Michael R Wiley; Stephen White; Julien Thézé; Diogo M Magnani; Karla Prieto; Daniel Reyes; Andrea M Bingham; Lauren M Paul; Refugio Robles-Sikisaka; Glenn Oliveira; Darryl Pronty; Carolyn M Barcellona; Hayden C Metsky; Mary Lynn Baniecki; Kayla G Barnes; Bridget Chak; Catherine A Freije; Adrianne Gladden-Young; Andreas Gnirke; Cynthia Luo; Bronwyn MacInnis; Christian B Matranga; Daniel J Park; James Qu; Stephen F Schaffner; Christopher Tomkins-Tinch; Kendra L West; Sarah M Winnicki; Shirlee Wohl; Nathan L Yozwiak; Joshua Quick; Joseph R Fauver; Kamran Khan; Shannon E Brent; Robert C Reiner; Paola N Lichtenberger; Michael J Ricciardi; Varian K Bailey; David I Watkins; Marshall R Cone; Edgar W Kopp; Kelly N Hogan; Andrew C Cannons; Reynald Jean; Andrew J Monaghan; Robert F Garry; Nicholas J Loman; Nuno R Faria; Mario C Porcelli; Chalmers Vasquez; Elyse R Nagle; Derek A T Cummings; Danielle Stanek; Andrew Rambaut; Mariano Sanchez-Lockhart; Pardis C Sabeti; Leah D Gillis; Scott F Michael; Trevor Bedford; Oliver G Pybus; Sharon Isern; Gustavo Palacios; Kristian G Andersen Journal: Nature Date: 2017-05-24 Impact factor: 49.962
Authors: Monica C Campos; Jamille G Dombrowski; Jody Phelan; Claudio R F Marinho; Martin Hibberd; Taane G Clark; Susana Campino Journal: PLoS One Date: 2018-08-15 Impact factor: 3.240
Authors: Ignacio Zarante; Paula Hurtado-Villa; Salimah R Walani; Vijaya Kancherla; Jorge López Camelo; Roberto Giugliani; Boris Groisman; Christopher P Howson; Pablo Durán Journal: Rev Panam Salud Publica Date: 2019-02-14
Authors: Nathan D Grubaugh; Sharada Saraf; Karthik Gangavarapu; Alexander Watts; Amanda L Tan; Rachel J Oidtman; Jason T Ladner; Glenn Oliveira; Nathaniel L Matteson; Moritz U G Kraemer; Chantal B F Vogels; Aaron Hentoff; Deepit Bhatia; Danielle Stanek; Blake Scott; Vanessa Landis; Ian Stryker; Marshall R Cone; Edgar W Kopp; Andrew C Cannons; Lea Heberlein-Larson; Stephen White; Leah D Gillis; Michael J Ricciardi; Jaclyn Kwal; Paola K Lichtenberger; Diogo M Magnani; David I Watkins; Gustavo Palacios; Davidson H Hamer; Lauren M Gardner; T Alex Perkins; Guy Baele; Kamran Khan; Andrea Morrison; Sharon Isern; Scott F Michael; Kristian G Andersen Journal: Cell Date: 2019-08-22 Impact factor: 41.582
Authors: Caroline T Weldon; Amy R Riley-Powell; Ines M Aguerre; Rosa A Celis Nacimento; Amy C Morrison; Richard A Oberhelman; Valerie A Paz-Soldan Journal: PLoS Negl Trop Dis Date: 2018-08-30
Authors: Chantal B F Vogels; Claudia Rückert; Sean M Cavany; T Alex Perkins; Gregory D Ebel; Nathan D Grubaugh Journal: PLoS Biol Date: 2019-01-22 Impact factor: 8.029